GIBU
MRNA icon

Gulf International Bank (UK)’s Moderna MRNA Stock Holding History

Gulf International Bank (UK)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,303
Closed -$547K – 617
2025
Q1 		$547K Sell
19,303
-6,053
-24% -$215K 0.02% 571
2024
Q4 		$1.05M Sell
25,356
-272
-1% -$13K 0.03% 475
2024
Q3 		$1.71M Sell
25,628
-1,186
-4% -$109K 0.04% 355
2024
Q2 		$3.18M Hold
26,814
– – 0.08% 228
2024
Q1 		$2.86M Buy
26,814
+228
+0.9% +$23K 0.07% 266
2023
Q4 		$2.64M Sell
26,586
-3,336
-11% -$281K 0.07% 264
2023
Q3 		$3.09M Sell
29,922
-3,158
-10% -$352K 0.09% 239
2023
Q2 		$4.02M Sell
33,080
-9,898
-23% -$1.32M 0.1% 202
2023
Q1 		$6.6M Sell
42,978
-13,886
-24% -$2.29M 0.14% 146
2022
Q4 		$10.2M Hold
56,864
– – 0.18% 115
2022
Q3 		$6.72M Hold
56,864
– – 0.13% 166
2022
Q2 		$8.12M Hold
56,864
– – 0.14% 143
2022
Q1 		$9.79M Hold
56,864
– – 0.15% 139
2021
Q4 		$14.4M Sell
56,864
-11,300
-17% -$3.3M 0.2% 96
2021
Q3 		$26.2M Buy
68,164
+3,881
+6% +$1.43M 0.34% 59
2021
Q2 		$15.1M Buy
64,283
+7,753
+14% +$1.39M 0.19% 106
2021
Q1 		$7.4M Sell
56,530
-6,000
-10% -$869K 0.1% 207
2020
Q4 		$6.53M Sell
62,530
-4,600
-7% -$465K 0.09% 244
2020
Q3 		$4.75M Sell
67,130
-550
-0.8% -$38.3K 0.07% 279
2020
Q2 		$4.34M Buy
+67,680
New +$3.71M 0.07% 288

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Gulf International Bank (UK)'s MRNA Position: Q2 2025 in Review

Gulf International Bank (UK) sold out of Moderna (MRNA) in Q2 2025, closing a stake of 19,303 shares — an estimated $547K sold.

Gulf International Bank (UK) first reported a position in MRNA in Q2 2020 and held it in 20 quarters. The position peaked at $26.2M in Q3 2021. 675 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Gulf International Bank (UK) reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Gulf International Bank (UK) sold 19,303 Moderna shares in Q2 2025, an estimated $547K.
  • Gulf International Bank (UK) first reported a position in Moderna in Q2 2020 and held it in 20 quarters.
  • Gulf International Bank (UK)'s Moderna position peaked at $26.2M in Q3 2021.
  • 675 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Gulf International Bank (UK)'s 13F filing for Q2 2025, filed 30 Jul 2025.